23 Nov

Admission and Quotation

Market Announcement 23 November 2021 23 November 2021 Market Announcement 1 / 2 ASX Limited ASX Customer Service Centre 131 279 | asx.com.au Radiopharm Theranostics Limited (ASX: RAD ) – Admission and Quotation Description Radiopharm Theranostics Limited (‘ RAD ’) was admitted to the O fficial List of ASX on Tuesday, 23 November 2021 . The securities of RAD will commence quotation at 11:00AM AEDT on Thursday, 25 November 2021 . RAD raised $49,999,999.80 pursuant to the offer under its prospectus dated 14 October 2021 and supplementary prospectus dated 28 O ctober 2021 by the issue of 83,333,333 shares at an issue price of $0.60 per share . Quotation information Quoted securities Fully paid ordinary shares: 116,666,984 ASX code Fully paid ordinary shares: RAD Time 11:00AM AEDT Date Thursday, 25 November 2021 ASX trade abbreviation RADIOPHARM ISIN Fully paid ordinary shares: AU0000181851 Registered office Radiopharm Theranostics Limited Address: Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Phone: (03) 9824 5254 Email: info@radiopharmtheranostics.com Company secretary Phillip Hains and Nathan Jong Share Registry Automic Pty Ltd Address: Level 5, 126 Phillip Street, Sydney NSW 2000 Phone: 1300 288 664 Email: hello@automic.com.au Balance date 30 June CHESS Participating. CHESS and Issuer Sponsored. Place of incorporation New South Wales, Australia Dividend policy See section 5.8 of the Prospectus Activities Clinical stage radiotherapeutics company Lead manager Bell Potter Securities Limited and Baker Young Limited Underwriter N/A 23 November 2021 Market Announcement 2 / 2 ASX restricted securities 100,000,000 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow until 25 November 2023 , being 24 months from the date of Quotation. 11,111,018 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow until 1 September 2022, being 12 months from the date of i ssue. 25,555,555 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow until 18 November 2022 , being 12 months from the date of issue. 5,700,006 options exercisable at $0.60 on or before 25 November 2025 , clas sified by ASX as restricted securities and to be held in escrow until 25 November 2023 , being 24 months from the date of Quotation. 8,666,678 options exercisable at $0.60 on or before 25 November 2026 , classified by ASX as restricted securities and t o be held in escrow until 25 November 2023 , being 24 months from the date of Quotation . 1 3 ,680,012 options exercisable at $0.90 on or before 25 November 2024, classified by ASX as restricted securities and to be held in escrow until 25 November 2023, bei ng 24 months from the date of Quotation. Other securities not quoted 5,066,672 options exercisable at $0.60 on or before 25 November 2026. Need more information? For further information, please refer to RAD ’s Prospectus . Need more information? For further information, please call the Company Secretary on (03) 9864 4839 or (03) 9864 4810. Disclaimer Please refer to the following disclaimer . Issued by Olivia Gong Adviser , Listings Compliance ( Melbourne )
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Radiopharm Theranostics Limited (ASX:RAD) when you join Listcorp.